Skip to content

Drug interactions

Disopyramide + Secukinumab

Severity: Minor

Disopyramide and Secukinumab: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Secukinumab may normalize CYP enzyme expression suppressed by chronic inflammation, which could change clearance of CYP3A4 substrates. Disopyramide has a narrow therapeutic index, so altered levels could affect arrhythmia control. The effect is theoretical.

What this interaction means in plain words

Disopyramide and Secukinumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Disopyramide belongs to Cardiovascular; Secukinumab belongs to Miscellaneous.

Evidence level: Low

Why it happens

Normalization of cytokine-suppressed CYP450 expression after IL-17A blockade, potentially increasing disopyramide metabolism.

What to do

Monitor ECG and antiarrhythmic response when secukinumab is started or stopped. Adjust the disopyramide dose as needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Disopyramide and Secukinumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Disopyramide with Secukinumab?

MediHelp rates the interaction as minor. Disopyramide and Secukinumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Secukinumab may normalize CYP enzyme expression suppressed by chronic inflammation, which could change clearance of CYP3A4 substrates. Disopyramide has a narrow therapeutic index, so altered levels could affect arrhythmia control. The effect is theoretical.

How serious is the interaction between Disopyramide and Secukinumab?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and antiarrhythmic response when secukinumab is started or stopped. Adjust the disopyramide dose as needed.

What other medicines interact with Secukinumab?

MediHelp also lists interactions of Secukinumab with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Secukinumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in